Pei Shu

5PUBLICATIONS
31CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 23, 2026
Parallel 4-1BB Signaling in Dual DLL3/CD56-Targeting CAR-T Cells Triggers Adaptive Proliferation and Functional Persistence to Eradicate Small Cell Lung Cancer.

|Nov 13, 2025
Anti-epidermal growth factor receptor monoclonal antibody combined with chemotherapy in penile cancer: A prospective, multicenter, phase 1 study.

Pei Shu, Shuang Zhang, Dingwei Ye

|Jul 22, 2025
Preclinical Development and Phase I Study of ZSYY001, a Polymeric Micellar Paclitaxel for Advanced Solid Tumor.

Ge Gao, Pei Shu, Youzhen Tan

|Apr 23, 2025
Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line treatment for advanced biliary tract cancer: perspectives from US and Chinese payers.

Can Jiang, Kexun Zhou, Pei Shu

|Oct 21, 2022
Long-Term Follow-Up Results of Adjuvant Intensity-Modulated Radiotherapy with Concurrent Paclitaxel and Cisplatin in High-Risk Endometrial Cancer Patients.

Pei Shu, Xin Wang, Ganlu Ouyang

Pageof 1

Frequent Collaborators

2 joint publications

Yongsheng Wang

1 joint publications

Xin Wang

1 joint publications

Ganlu Ouyang

1 joint publications

Jitao Zhou